American Journal of Clinical Pathology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Acute leukemia with cytogenetically cryptic FGFR1 rearrangement and lineage switch during therapy: A case report and literature review
CONCLUSIONS: Ours is the only reported case of FGFR1-rearranged neoplasms with a disease sequence of acute myeloid leukemia transforming to B-cell acute lymphoblastic leukemia and 1 of only 3 reported cases with cytogenetically cryptic FGFR1 rearrangement. Fluorescence in situ hybridization testing for FGFR1 rearrangement should be a standard investigation in leukemia of mixed or switching lineage.PMID:37855739 | DOI:10.1093/ajcp/aqad135 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - October 19, 2023 Category: Pathology Authors: Sean J McKeague Kacey O'Rourke Stephen Fanning Christopher Joy Duncan Throp Rebecca Adams Yasmin Harvey Tee Beng Keng Source Type: research
Acute leukemia with cytogenetically cryptic FGFR1 rearrangement and lineage switch during therapy: A case report and literature review
CONCLUSIONS: Ours is the only reported case of FGFR1-rearranged neoplasms with a disease sequence of acute myeloid leukemia transforming to B-cell acute lymphoblastic leukemia and 1 of only 3 reported cases with cytogenetically cryptic FGFR1 rearrangement. Fluorescence in situ hybridization testing for FGFR1 rearrangement should be a standard investigation in leukemia of mixed or switching lineage.PMID:37855739 | DOI:10.1093/ajcp/aqad135 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - October 19, 2023 Category: Pathology Authors: Sean J McKeague Kacey O'Rourke Stephen Fanning Christopher Joy Duncan Throp Rebecca Adams Yasmin Harvey Tee Beng Keng Source Type: research
Acute leukemia with cytogenetically cryptic FGFR1 rearrangement and lineage switch during therapy: A case report and literature review
CONCLUSIONS: Ours is the only reported case of FGFR1-rearranged neoplasms with a disease sequence of acute myeloid leukemia transforming to B-cell acute lymphoblastic leukemia and 1 of only 3 reported cases with cytogenetically cryptic FGFR1 rearrangement. Fluorescence in situ hybridization testing for FGFR1 rearrangement should be a standard investigation in leukemia of mixed or switching lineage.PMID:37855739 | DOI:10.1093/ajcp/aqad135 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - October 19, 2023 Category: Pathology Authors: Sean J McKeague Kacey O'Rourke Stephen Fanning Christopher Joy Duncan Throp Rebecca Adams Yasmin Harvey Tee Beng Keng Source Type: research
Acute leukemia with cytogenetically cryptic FGFR1 rearrangement and lineage switch during therapy: A case report and literature review
CONCLUSIONS: Ours is the only reported case of FGFR1-rearranged neoplasms with a disease sequence of acute myeloid leukemia transforming to B-cell acute lymphoblastic leukemia and 1 of only 3 reported cases with cytogenetically cryptic FGFR1 rearrangement. Fluorescence in situ hybridization testing for FGFR1 rearrangement should be a standard investigation in leukemia of mixed or switching lineage.PMID:37855739 | DOI:10.1093/ajcp/aqad135 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - October 19, 2023 Category: Pathology Authors: Sean J McKeague Kacey O'Rourke Stephen Fanning Christopher Joy Duncan Throp Rebecca Adams Yasmin Harvey Tee Beng Keng Source Type: research
Acute leukemia with cytogenetically cryptic FGFR1 rearrangement and lineage switch during therapy: A case report and literature review
CONCLUSIONS: Ours is the only reported case of FGFR1-rearranged neoplasms with a disease sequence of acute myeloid leukemia transforming to B-cell acute lymphoblastic leukemia and 1 of only 3 reported cases with cytogenetically cryptic FGFR1 rearrangement. Fluorescence in situ hybridization testing for FGFR1 rearrangement should be a standard investigation in leukemia of mixed or switching lineage.PMID:37855739 | DOI:10.1093/ajcp/aqad135 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - October 19, 2023 Category: Pathology Authors: Sean J McKeague Kacey O'Rourke Stephen Fanning Christopher Joy Duncan Throp Rebecca Adams Yasmin Harvey Tee Beng Keng Source Type: research
A Korean family with RHD*DNT only detectable after anti-D alloimmunization
CONCLUSIONS: We recommend DNT individuals as candidates for Rh immune globulin prophylaxis during the perinatal period and transfusions with D- blood components. An anticipatory RHD genotyping is suggested for partial D family members to prevent potential partial D individuals from becoming alloimmunized.PMID:37852281 | DOI:10.1093/ajcp/aqad132 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - October 18, 2023 Category: Pathology Authors: Dong Woo Shin Gun-Hyuk Lee Hanah Kim Kyeong A So Yun Ji Hong Mina Hur Kyoung Un Park Source Type: research
A Korean family with RHD*DNT only detectable after anti-D alloimmunization
CONCLUSIONS: We recommend DNT individuals as candidates for Rh immune globulin prophylaxis during the perinatal period and transfusions with D- blood components. An anticipatory RHD genotyping is suggested for partial D family members to prevent potential partial D individuals from becoming alloimmunized.PMID:37852281 | DOI:10.1093/ajcp/aqad132 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - October 18, 2023 Category: Pathology Authors: Dong Woo Shin Gun-Hyuk Lee Hanah Kim Kyeong A So Yun Ji Hong Mina Hur Kyoung Un Park Source Type: research
Reply to "C-reactive protein and erythrocyte sedimentation rate in inflammatory lesions: erythrocyte sedimentation rate test is essential in a subset of patients"
Am J Clin Pathol. 2023 Oct 16:aqad126. doi: 10.1093/ajcp/aqad126. Online ahead of print.NO ABSTRACTPMID:37842811 | DOI:10.1093/ajcp/aqad126 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - October 16, 2023 Category: Pathology Authors: Dawi Shin Hyung J Cho Source Type: research
C-reactive protein and erythrocyte sedimentation rate in inflammatory lesions: Erythrocyte sedimentation rate test is essential in a subset of patients
Am J Clin Pathol. 2023 Oct 16:aqad125. doi: 10.1093/ajcp/aqad125. Online ahead of print.NO ABSTRACTPMID:37842812 | DOI:10.1093/ajcp/aqad125 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - October 16, 2023 Category: Pathology Authors: Gurmukh Singh Source Type: research
Large language model's utility in helping pathology professionals
Am J Clin Pathol. 2023 Oct 16:aqad130. doi: 10.1093/ajcp/aqad130. Online ahead of print.NO ABSTRACTPMID:37843400 | DOI:10.1093/ajcp/aqad130 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - October 16, 2023 Category: Pathology Authors: Hinpetch Daungsupawong Viroj Wiwanitkit Source Type: research
Reply to "C-reactive protein and erythrocyte sedimentation rate in inflammatory lesions: erythrocyte sedimentation rate test is essential in a subset of patients"
Am J Clin Pathol. 2023 Oct 16:aqad126. doi: 10.1093/ajcp/aqad126. Online ahead of print.NO ABSTRACTPMID:37842811 | DOI:10.1093/ajcp/aqad126 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - October 16, 2023 Category: Pathology Authors: Dawi Shin Hyung J Cho Source Type: research
C-reactive protein and erythrocyte sedimentation rate in inflammatory lesions: Erythrocyte sedimentation rate test is essential in a subset of patients
Am J Clin Pathol. 2023 Oct 16:aqad125. doi: 10.1093/ajcp/aqad125. Online ahead of print.NO ABSTRACTPMID:37842812 | DOI:10.1093/ajcp/aqad125 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - October 16, 2023 Category: Pathology Authors: Gurmukh Singh Source Type: research
Large language model's utility in helping pathology professionals
Am J Clin Pathol. 2023 Oct 16:aqad130. doi: 10.1093/ajcp/aqad130. Online ahead of print.NO ABSTRACTPMID:37843400 | DOI:10.1093/ajcp/aqad130 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - October 16, 2023 Category: Pathology Authors: Hinpetch Daungsupawong Viroj Wiwanitkit Source Type: research
Clinicopathologic characterization of cutaneous adult T-cell leukemia/lymphoma: A single tertiary care center experience in the United States
CONCLUSIONS: Pleomorphic large, atypical cells with CD4+/CD25+/CD7- immunophenotype from a non-"bathing trunk" location, especially in a patient from endemic regions, raise suspicion for ATLL. T-cell receptor gene rearrangement is almost always positive, and the neoplasm usually demonstrates multiple mutations by next-generation sequencing study.PMID:37830309 | DOI:10.1093/ajcp/aqad120 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - October 13, 2023 Category: Pathology Authors: Mitul B Modi Alexandra Kiszluk Jiani N Chai Ukuemi Edema Maxwell Y Ma R Alejandro Sica Yanhua Wang Yang Shi Source Type: research
Hemophagocyte morphology and hypertriglyceridemia correlate with diagnosis of hemophagocytic lymphohistiocytosis in patients with bone marrow hemophagocytes
CONCLUSIONS: The presence of hypertriglyceridemia and more frequent gHPC has predictive value for HLH diagnosis in patients with bone marrow HPC.PMID:37833042 | DOI:10.1093/ajcp/aqad131 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - October 13, 2023 Category: Pathology Authors: Mingfei Yan Rose C Beck Ramya Gadde Source Type: research